Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on April 8, 2025
Notification de mise à jour des résolutions proposées à l’Assemblée Générale Annuelle des actionnaires 2025 de STMicroelectronics
GlobeNewswire
·
April 8, 2025
PR N°C3328C Notification de mise à jour des résolutions proposées à l’Assemblée Générale Annuelle des actionnaires 2025 de STMicroelectronics Amsterdam, le 8 avril 2025 – STMicroelectronics (NYSE : STM), un leader mondial des semiconducteurs dont les …
NowVertical Group Wins 2025 Google Cloud Data & Analytics Partner of the Year for Latin America
GlobeNewswire
·
April 8, 2025
TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) ("NowVertical" or the "Company"), a leading data and AI solutions provider, announced today that it has received the 2025 Google Cloud Data …
Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease
GlobeNewswire
·
April 8, 2025
HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the closing of a $ …
National Minority Quality Forum Announces 2025 National Minority Health Month Theme: “Health Unlocked: Access, Alignment, Action”
GlobeNewswire
·
April 8, 2025
Washington, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- The National Minority Quality Forum (NMQF) proudly announces the 2025 theme for National Minority Health Month: “Health Unlocked: Access, Alignment, Action.” This year’s theme recognizes the evolving …
Myriad Genetics Announces Inducement Awards
GlobeNewswire
·
April 8, 2025
SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today that in connection with the hiring of Mr. Donnelly as chief commercial officer, …
Satellogic Awarded $30 Million Contract for Its AI-First Constellation Services
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in high-resolution Earth observation data, has been awarded a multi-year contract valued at $30 million to provide near-daily and ultra-low latency analytics from its …
AMD to Report Fiscal First Quarter 2025 Financial Results
GlobeNewswire
·
April 8, 2025
SANTA CLARA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal first quarter 2025 financial results on Tuesday, May 6, 2025, after the close of market. Management will conduct a conference call to …
NioBay reçoit une subvention de 400 000 $
GlobeNewswire
·
April 8, 2025
MONTRÉAL, 08 avr. 2025 (GLOBE NEWSWIRE) -- Les Métaux NioBay inc. (« NioBay » ou la « Société ») (TSX-V: NBY) (OTCQB: NBYCF) est fière d’annoncer l’octroi d’une subvention dans le cadre du Programme de soutien à l’exploration minière pour les minéraux …
NioBay Receives $400,000 Grant
GlobeNewswire
·
April 8, 2025
MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce the award of a grant under the Mining Exploration Support Program for Critical and Strategic Minerals of the …
Vicor Corporation to Hold First Quarter Earnings Conference Call and Webcast on April 29, 2025
GlobeNewswire
·
April 8, 2025
ANDOVER, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) announced today it will hold its first quarter 2025 earnings conference call and webcast on Tuesday, April 29, 2025 at 5:00 p.m. (Eastern). Prepared remarks regarding the …
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
GlobeNewswire
·
April 8, 2025
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
GlobeNewswire
·
April 8, 2025
SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
GlobeNewswire
·
April 8, 2025
CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that …
Lesaka to Host Webcast to Review Third Quarter 2025 Results
GlobeNewswire
·
April 8, 2025
JOHANNESBURG, April 08, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (NASDAQ:LSAK, JSE: LSK) ("Lesaka" or the "Company") today announced it will release third quarter 2025 results after the U.S. market close on May 7, 2025. Lesaka management will …
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
GlobeNewswire
·
April 8, 2025
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI …
FormFactor Introduces the EVOLVITY™ 300 Probe System
GlobeNewswire
·
April 8, 2025
LIVERMORE, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a supplier of electrical test and measurement technologies, has introduced the EVOLVITY™ 300, a semi-automated engineering wafer probe system that complements the …
Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
GlobeNewswire
·
April 8, 2025
Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease Education Campaign for Healthcare Providers called Move GBS Forward …
Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 8, 2025
NX-5948 assigned the nonproprietary name “bexobrutideg” U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemia Achieved $7M in milestones and a $15M license extension fee from ongoing collaboration with …
Toll Brothers Announces Final Opportunity at Elevate by Toll Brothers at Great Park Neighborhoods in Irvine, California
GlobeNewswire
·
April 8, 2025
IRVINE, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to own a new home at Elevate by Toll Brothers at Great Park Neighborhoods in Irvine, …
Alectra Utilities committed to seeking increased procurement of Canadian goods and materials for its electricity distribution operations
GlobeNewswire
·
April 8, 2025
MISSISSAUGA, Ontario, April 08, 2025 (GLOBE NEWSWIRE) -- Alectra Utilities (Alectra) announced today its commitment to prioritizing Canadian businesses, suppliers, and vendors through its procurement processes for equipment and services for its electricity …